New mouse research from WashU Medicine suggests the immune cells that fuel tau-driven brain damage are trained in lymph nodes outside the brain, opening the door to treatments that never need to cross the blood-brain barrier.
Two infants with leukemia are now in remission, thanks to a world-first treatment that uses genetically engineered T-cells from healthy donors. The UK patients were first given the treatment back in 2015, after chemotherapy failed to show results. Now, after... Continue Reading →